NCT05885828 The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes
| NCT ID | NCT05885828 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Westlake University |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-07-17 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-07-17 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Food plays a crucial role in determining blood glucose levels, especially in people with type 2 diabetes. Precision nutrition, which involves individually tailored dietary interventions, can be a powerful tool in managing blood glucose levels in people with type 2 diabetes. Previous studies found that changes in gut microbiota resulted from the dietary intervention, such as plant-based diet, might subsequently lead to different glycemic responses, and then different health outcomes. In this study, the investigators will characterize the blood glucose dynamics and gut microbiota of individuals with type 2 diabetes. They aim to assess the influence of plant-based diet on gut microbiota; they will also investigate the influence of gut microbiota on glycemic responses. Additionally, a series of individual N-of-1 trails will be integrated to compare the effects of a white bread breakfast and a whole wheat bread breakfast on glucose metabolism at the individual level.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with type 2 diabetes; * Living in Hangzhou for at least five years; * Have the willingness or ability to complete the intervention and sample collection Exclusion Criteria: * Mental and physical disability; * Already is a vegetarian; * Cancer and serious complications from type 2 diabetes, such as renal failure; * Using insulin for more than 5 years; * Unstable medical/medication status; * Current alcohol or drug abuse; * Taking antibiotics in the last three months
Contact & Investigator
Ju-Sheng Zheng, PhD
PRINCIPAL INVESTIGATOR
Westlake University
Frequently Asked Questions
Who can join the NCT05885828 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 75 Years, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05885828 currently recruiting?
Yes, NCT05885828 is actively recruiting participants. Contact the research team at zhengjusheng@westlake.edu.cn for enrollment information.
Where is the NCT05885828 trial being conducted?
This trial is being conducted at Hangzhou, China, Hangzhou, China.
Who is sponsoring the NCT05885828 clinical trial?
NCT05885828 is sponsored by Westlake University. The principal investigator is Ju-Sheng Zheng, PhD at Westlake University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.